Valerie Kuenzli, MD
Family Medicine · Columbus, OHNPI 1710147509
Payments from drug & device makers
Across 127 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$297
- AbbVie$270
- GSK$240
- AstraZeneca$125
- Takeda Pharmaceuticals U.S.A., Inc.$118
- Pfizer$89
- plus $778 from 26 others
What the payments were for
- Food & beverage$1,911100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $297 |
| AbbVie(2 entities) | 18 | $270 |
| GSK | 16 | $240 |
| AstraZeneca | 8 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $118 |
| Pfizer | 6 | $89 |
| Exact Sciences | 3 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Amarin Pharma, Inc. | 4 | $62 |
| Amgen | 4 | $58 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Sunovion Pharmaceuticals Inc. | 4 | $56 |
| Lilly USA, LLC | 3 | $40 |
| Boehringer Ingelheim | 3 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Covis Pharma GmbH | 2 | $28 |
| Johnson & Johnson | 2 | $27 |
| Dexcom, Inc. | 1 | $23 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Neos Therapeutics, LP | 1 | $15 |
| Novartis | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Mylan Specialty L.p. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| IBSA Pharma Inc. | 1 | $11 |
How this compares
$1,917 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $43,685 |
| JardianceEmpagliflozin | 54 | $40,206 |
| TrulicityDulaglutide | 16 | $29,237 |
| OzempicSemaglutide | 21 | $26,691 |
| JanuviaSitagliptin Phosphate | 30 | $18,149 |
| MounjaroTirzepatide | 12 | $13,165 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,668 |
| Atorvastatin Calcium | 193 | $2,025 |
| Duloxetine Hcl | 36 | $1,853 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $1,356 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,273 |
| Oxycodone Hcl | 40 | $966 |
| SynthroidLevothyroxine Sodium | 24 | $882 |
| Losartan Potassium | 97 | $880 |
| Bupropion XlBupropion Hcl | 37 | $751 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $89 | $43,68548 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $40 | $42,40228 claims |
| Boehringer IngelheimJardiance | $38 | $40,20654 claims |
| Novo NordiskOzempic | $297 | $26,69121 claims |
| MerckJanuvia | $13 | $18,14930 claims |
| GSKShingrix | $240 | $2,66812 claims |
| AbbVieSynthroid | $270 | $88224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Columbus
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
- Robert FloreaColumbus$955K
- Bryan FeldmanColumbus$404K
- Scott MerrymanColumbus$89K
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.